Gravar-mail: DOSE DEPENDENCE AND THERAPEUTIC WINDOW FOR THE NEUROPROTECTIVE EFFECTS OF 17β-ESTRADIOL WHEN ADMINISTERED AFTER CEREBRAL ISCHEMIA